These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18799190)

  • 1. Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma.
    Nalesnik MA; Federle M; Buck D; Fontes P; Carr BI
    Hum Pathol; 2009 Jan; 40(1):125-34. PubMed ID: 18799190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
    Kennedy AS; Nutting C; Coldwell D; Gaiser J; Drachenberg C
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1552-63. PubMed ID: 15590187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.
    Goin JE; Salem R; Carr BI; Dancey JE; Soulen MC; Geschwind JF; Goin K; Van Buskirk M; Thurston K
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):195-203. PubMed ID: 15713920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma.
    Allison C
    Issues Emerg Health Technol; 2007 Sep; (102):1-6. PubMed ID: 17824141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma.
    Liu MD; Uaje MB; Al-Ghazi MS; Fields D; Herman J; Kuo JV; Milne N; Nguyen TH; Ramsinghani NS; Tokita KM; Tsai FY; Vajgrt DJ; Imagawa DK
    Am Surg; 2004 Nov; 70(11):947-53. PubMed ID: 15586503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
    Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
    Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
    Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE
    J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
    Dawson LA
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report.
    Kulik LM; Mulcahy MF; Hunter RD; Nemcek AA; Abecassis MM; Salem R
    Liver Transpl; 2005 Sep; 11(9):1127-31. PubMed ID: 16123954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors.
    Neff R; Abdel-Misih R; Khatri J; Dignazio M; Garcia M; Petrelli N; Wilson P
    Cancer Invest; 2008 Mar; 26(2):173-7. PubMed ID: 18259948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma.
    Fleming CJ; Andrews JC; Wiseman GA; Gansen DN; Roberts LR
    J Vasc Interv Radiol; 2009 Nov; 20(11):1460-3. PubMed ID: 19875064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
    Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
    Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
    Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
    Salem R; Lewandowski RJ; Atassi B; Gordon SC; Gates VL; Barakat O; Sergie Z; Wong CY; Thurston KG
    J Vasc Interv Radiol; 2005 Dec; 16(12):1627-39. PubMed ID: 16371529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.
    Kamel IR; Reyes DK; Liapi E; Bluemke DA; Geschwind JF
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):49-56. PubMed ID: 17296704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.
    Salem R; Hunter RD
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S83-8. PubMed ID: 16979447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric radiation enteritis after intra-arterial yttrium-90 microsphere therapy for early stage hepatocellular carcinoma.
    Aloia TA; Barakat O; Connelly J; Haykal N; Michel D; Gaber AO; Ghobrial RM
    Exp Clin Transplant; 2009 Sep; 7(3):141-4. PubMed ID: 19715522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
    Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G
    Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere).
    Steel J; Baum A; Carr B
    Psychooncology; 2004 Feb; 13(2):73-9. PubMed ID: 14872525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.